FDA grants TiGenix therapy orphan drug designation & more — 5 GI company key notes

Here are five updates on GI companies from the past week:

Advertisement

The FDA granted TiGenix orphan drug designation for Cx601, its lead candidate which treats fistulizing Crohn’s disease.

Apollo Endosurgery entered into a registry funding agreement with the American Gastroenterological Association to develop a flexible endoscopic procedures registry.

Ambu acquired Invendo Medical and its single-use endoscope business for €225 million ($265 million.)

The UK Medicines and Healthcare Products Regulatory Agency approved Norgine B.V.’s bowel cleaning solution Plenvu.

More articles on gastroenterology:
GI leader to know: Dr. Umaprasanna Karnam of Gut Whisperer Center for Digestive Health
Stock market week-in-review for 5 large GI companies — Oct. 16-20
To prevent injury, gastroenterologists should complete more ergonomics training, take breaks

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • OSF HealthCare Saint Anthony Medical Center in Rockford, Ill., has added Tarik Firozi, MD, according to an April 6 report…

  • Miami-based Gastro Health has finalized a partnership with Digestive Disease Physicians, an Alexandria, Va.-based gastroenterology practice, according to an April…

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

Advertisement

Comments are closed.